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We can all remember individual children in whom a deterioration went unrecognised. Sometimes 
fatally. Our defences were little more than the pearls offered by senior colleagues of grave warning 
signs: ‘beware grunting in an infant’ or ‘watch out for a tachycardia after the temperature has 
fallen’. But this advice was unstructured, and children are so different, and their co-morbidities so 
broad we failed some of them. Paediatric Early Warning Systems (PEWS) are serious attempts to 
reduce the unacceptable and dangerous variability in this recognition and response process. Scoring 
systems should provide age-appropriate thresholds for concern for single parameters or aggregated 
abnormal physiology and prompt standardised responses. The idea has such natural appeal that 
PEWS use was soon advocated by a number of national bodies [1,2] without evidence. This may have 
been a mistake. Many of the scores in widespread use were not calibrated nor validated. When 
formally assessed, most had poor predictive performance.[3] This is not a trivial problem because 
staff may choose not to raise an alarm in the absence of a raised score or may choose to ignore a 
score ‘because it never works for him/her’. 
Other than optimism, the main reason for the lack of evidence was the low event rates of critical 
deterioration or death within individual centres. An adequately powered trial was therefore a huge 
challenge. Fortunately, Parshuram and colleagues took on this challenge with the study Effect of a 
PEWS on All-Cause Mortality in Hospitalized Pediatric Patients – EPOCH.[4] This trial has many 
strengths. It assessed a strong candidate for a score: the BedsidePEWS. The BedsidePEWS is notable 
for having significant prior validation.[5,6] It was one of the highest performing of 18 scores in head 
to head comparisons.[3] Further, it addressed a relevant and very large population: 144,539 patients 
in 21 hospitals in seven countries. The intervention was well designed and formally implemented. 
The validated severity of illness score was implemented alongside an education program with inter-
professionally designed documentation and structured escalation/de-escalation care 
recommendations. The cluster-randomised design was efficient and the only feasible approach to 
avoid contamination. The outcome measures were relevant to patients and families: the primary 
being all-cause hospital mortality. Secondary measures included occurrence of a significant clinical 
deterioration event, a composite measure felt to reflect late admission to intensive care (Table 1). 
Ten hospitals were randomized to the BedsidePEWS intervention. The remaining 11 hospitals did not 
have a PEWS, although four did have a rapid response team in situ. 
  
Table 1: Significant Clinical Deterioration Event component outcomes 
Within the 12 hours before intensive care 
admission 
Within first hour after intensive care admission 
Death  Death 
Cardiopulmonary resuscitation Cardiopulmonary resuscitation 
Tracheal intubation Tracheal intubation 
Administration of vasoactive medication  Extracorporeal membrane oxygenation 
Fluid boluses of 60 mL/kg or greater   
Occurrence of one or more component outcomes would be considered a significant clinical deterioration event 
Despite all these strengths, EPOCH was a ‘negative trial’. Implementing the BedsidePEWS did not 
significantly decrease all-cause mortality. Of the 22 secondary outcome measures the only positive 
finding was a reduction in significant clinical deterioration events (relative risk 0.77 (0.61 to 0.97), 
p=0 .03).  
So what is to be made of this? Should governments and organisations no longer recommend PEWS? 
Should hospitals consider removing a PEWS which is already in place or not go forward with 
implementing a PEWS in the future?  
If we look a little more closely at the main outcome measure of all-cause hospital mortality, we can 
see that this presents some challenges, particularly as death in childhood remains, thankfully, a 
relatively rare event. The power calculations were based on 2007-2009 data with baseline all-cause 
hospital mortality of 5.1 deaths per 1000 hospital discharges and anticipated a reduction of 1/1000 
hospital discharges. However there has been a general reduction in mortality over time [7] which 
invalidated these power calculations. The trial observed fewer than 2 deaths per 1000 hospital 
discharges in both groups and roughly half of these deaths were in the context of ‘do not attempt 
resuscitation’ orders (DNAR). Exclusion of children with a DNAR did not alter the findings. The study 
was therefore underpowered despite the 21 hospitals and 144,539 patients. Assuming mortality fell 
no further, to detect a 10% relative risk reduction (from 2/1000 to 1.8/1000) with 90% power of in-
hospital deaths in the absence of a DNAR would require a study of >2 million individually randomised 
paediatric admissions. And individual randomisation is not feasible for an intervention such as this. 
The necessary cluster randomisation would require many hospitals and a significantly higher number 
of patients.[8] Also, children die for different reasons than they did 10-15 years ago.[9] Severe or 
multiple co-morbidities are the dominant causes of in-hospital death and the contribution from 
severely deranged acute physiology is less than it ever was.[10] So, a potential effect size of 10% 
may be unrealistic. Therefore the required sample size increases into many millions.  
Whilst no-one would argue that mortality is not important, is it the most appropriate outcome to 
assess PEWS efficacy? Some cases remain resistant to intervention and death will occur regardless of 
whether a PEWS is truly effective or not. If mortality is not the optimal outcome, what are the 
alternatives? The EPOCH team examined potentially preventable cardiac arrests. This has significant 
appeal but has been challenged as subjective. Initial efforts were hampered by low levels of reviewer 
agreement, prompting amendments to the previous agreed protocol. 
Ensuring rapid intensive care access for those who would benefit from it may be a better marker, 
given the purpose of PEWS. Within EPOCH the authors used significant clinical deterioration events 
as a marker of late transfers but closer examination reveals components associated with critical 
illness that is well established. The thresholds may be inappropriately high and children deemed to 
be a ‘timely’ transfer may in fact have been inappropriately classified. This may have masked the 
true effect of PEWS. Some of these critical events, such as cardiopulmonary resuscitation, tracheal 
intubation and death occurring outside or immediately on arrival to intensive care may indicate a 
lost opportunity for preventative action.  
As well as challenges relating to the appropriateness of the outcome measures, the EPOCH authors 
also faced the complexities of conducting a randomised trial in a real-world setting, where 
organisational culture and human interaction are pivotal. The successful deployment of a PEWS is 
dependent upon the complex interplay between multiple factors such as leadership, culture, 
teamwork, nurse and family empowerment, safe staffing levels, effective communication and 
continuity of care [11], which take time and effort to be embedded in practice. Data collection for 
the EPOCH trial may not have continued long enough, following the introduction of PEWS, for the 
long-term benefits (or harms) to be identified. 
Whilst detecting and managing deterioration in children is complex, the need for systems to deal 
with avoidable deterioration is not disputed. For this we need to agree robust, valid and clinically 
meaningful outcomes to evaluate patient safety efforts, not matter how challenging that might be. 
The BedsidePEWS is better validated than other systems, performs very well in head to head 
comparisons and with EPOCH has clear 1A evidence that it is not harmful. Determining a mortality 
effect may have been unrealistic given the many steps between deterioration and death, but we 
should take serious note of the significant critical deterioration signal. The EPOCH trial remains a 
valuable study and no other PEWS has anything approaching this level of evidence to support it. In 
evaluating PEWS, death is not the answer.   
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